Serum Paraoxonase 1 and Gene Polymorphism (PON- Q192R) as an Atherosclerotic Marker in Chronic Kidney Disease Patients in Menoufia University Hospitals- Egypt

Paraoxonase Activity as a Biochemical Indicator of Dyslipidaemia in Diabetes Mellitus Type 2 and Ischemic Heart Disease

Paraoxonase1 (PON1) 55 and 192 Polymorphism in Egypt and its impact on the antioxidant status of patients with Bilharzial and Viral liver diseases

Lipid Profile, Body Mass Index and Paraoxonase 1 Activity: Do They Correlate with Paraoxonase1 192 Polymorphism in Egyptians with Coronary Heart Disease

Serum Paraoxonase-1 (PON1) Activity and Concentration: A new biomarker in Egyptian Patients with Liver Cirrhosis and Hepatocellular Carcinoma

Assessment of serum c-peptide level as a risk factor for atherosclerosis and myocardial dysfunction in Egyptian patients with type 2 DM

Relation of Serum Lipoprotein (a) and Severity of Coronary Artery Disease in Type 2 Diabetic Patients

AStudy on APO B100/APO A1 Ratio as A Predictive Parameter for Assessmentof CAD Risk in Uncontrolled Type 2 Egyptian Diabetic Patients

Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population

The Relation Between Serum Chemerin Level and Atherosclerosis in Type II Diabetic Patients with and Without Coronary Artery Disease